Javascript is not activated in your browser. This website needs javascript activated to work properly.
Du är här

MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.

Publiceringsår: 2011
Språk: Engelska
Sidor: 211-220
Publikation/Tidskrift/Serie: Journal of Proteomics
Volym: 75
Nummer: 1
Dokumenttyp: Artikel
Förlag: Elsevier


As a proof-of-principle study, a multiple reaction monitoring (MRM) assay was developed for quantitation of proteotypic peptides, representing seven plasma proteins associated with inflammation (complement components and C-reactive protein). The assay development and the sample analysis were performed on a linear ion trap mass spectrometer. We were able to quantify 5 of the 7 target proteins in depleted plasma digests with reasonable reproducibility over a 2 orders of magnitude linear range (RSD < 25%). The assay panel was utilized for the analysis of a small multiple sclerosis sample cohort with 10 diseased and 8 control patients.



  • Medicine and Health Sciences
  • linear ion trap
  • multiple sclerosis
  • selective reaction monitoring


  • ISSN: 1876-7737

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen